Seoul National University Airway Registry

Airway Registry for Chronic Airway Diseases

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02527486

Enrollment

800

Registered

2015-08-19

Start date

2011-09-30

Completion date

2031-12-31

Last updated

2015-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Asthma With Chronic Obstructive Pulmonary Disease, Bronchiectasis, Chronic Obstructive Airway Disease, Chronic Obstructive Pulmonary Disease (COPD), Inactive Tuberculosis of Lung

Keywords

COPD, Asthma, ACOS, Bronchiectasis

Brief summary

This is a multicenter, prospective observational cohort study, in which patients with chronic airway diseases including chronic obstructive pulmonary disease(COPD), asthma, asthma-COPD overlap syndrome (ACOS) will be recruited.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 90 Years

Healthy volunteers

Inclusion criteria

COPD Inclusion Criteria: * Postbronchodilator FEV1/FVC \< 0.7 AND chronic respiratory symptom

Exclusion criteria

\- Asthma Inclusion Criteria: * Never smoker or \<5PY of smoking history AND Recurrent episodes of asthma symptoms (wheezing, dyspnea, chest tightness, cough) AND (either Positive BDR OR positive metacholine/mannitol/exercise provocation test)

Design outcomes

Primary

Measure	Time frame	Description
Death (time to death)	upto 20 years	death from any cause, death from COPD-specific cause, death from CVD, malignancy

Secondary

Measure	Time frame
post-bronchodilator FEV1 change rates	upto 20 years (at least 3 years)

Other

Measure	Time frame	Description
Time to 1st exacerbation (definition of exacerbation is described below)	upto 20 years	Definition of exacerbation: Airway disease symptom aggravation requiring either (1) Use of antibiotics or steroid, or (2) visiting ER or hospitalization
Annual rate of exacerbation (definition of exacerbation is described below)	upto 20 years	Definition of exacerbation: Airway disease symptom aggravation requiring either (1) Use of antibiotics or steroid, or (2) visiting ER or hospitalization

Countries

South Korea

Contacts

Primary ContactChang-Hoon Lee, M.D.

kauri670@gmail.com82-2-2072-4743

Outcome results